Healthcare Digest of Vermont: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Digest of Vermont.

Press releases published on May 29, 2026

an hour ago

Kun Peng International Ltd. Announces 1-for-10 Reverse Stock Split

Indeterminate GlobeNewswire

an hour ago

Dr. Matthew T. Provencher Receives Prestigious 2026 Stephen S. Burkhart Shoulder Innovation Research Award

Indeterminate GlobeNewswire

an hour ago

MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes

Indeterminate GlobeNewswire

5 hours ago

The Next Great AI Revolution May Be Drug Delivery

Indeterminate GlobeNewswire

5 hours ago

BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development

Indeterminate GlobeNewswire

5 hours ago

The Vision Council Foundation, AccuWeather®, and The Skin Cancer Foundation Unite for National Sunglasses Day 2026

Indeterminate GlobeNewswire

5 hours ago

Cannabix Expands BreathLogix Alcohol Screening Technology into Mining, Municipal and Aviation Sectors in Australia

Indeterminate GlobeNewswire

5 hours ago

SRx Health Solutions Invests in Uber Technologies, Inc. and Provides Shareholders with Portfolio Update

Indeterminate GlobeNewswire

5 hours ago

Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment

Indeterminate GlobeNewswire

5 hours ago

Sparrow Pharmaceuticals to Present Phase 2a Results for Clofutriben in Type 2 Diabetes at the 2026 American Diabetes Association (ADA) Scientific Session

Indeterminate GlobeNewswire

5 hours ago

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia

Indeterminate GlobeNewswire

5 hours ago

Imviva Biotech to Present Data from Clinical Studies of CTA313 and CTD402 Validating its ANSWER™ Allogeneic CAR-T Platform in Pediatric and Adult Patient Populations at EULAR and EHA 2026 Congresses

Indeterminate GlobeNewswire

5 hours ago

SkyAI Appoints Veteran Finance Executive Arthur Levine as Chief Financial Officer

Indeterminate GlobeNewswire

6 hours ago

AEON Clinic Redefines Longevity with Premier NAD+ IV Therapy and Premium IV Drips in Dubai

Indeterminate GlobeNewswire

6 hours ago

Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits

Indeterminate GlobeNewswire

6 hours ago

Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25

Indeterminate GlobeNewswire

6 hours ago

Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy

Indeterminate GlobeNewswire

6 hours ago

SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting

Indeterminate GlobeNewswire

6 hours ago

Omniscient Secures USD 27.2M Series D to Accelerate Commercialization of AI-Enabled Brain Technology

Indeterminate GlobeNewswire

6 hours ago

PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026

Indeterminate GlobeNewswire